AI & Machine Learning Investors & VC Firms in Europe
1861 firms in this list, with a median first check of $500K. 573 of them lead rounds. Generated from verified public data and updated continuously.
BY Venture Partners
St HelierPre-Seed–Series B$100K – $1M
15 people
RAED Ventures
RiyadhPre-Seed–Series A
31 people
Taisu Ventures
Pre-Seed–Series A
13 people
Meritech Capital Partners
Palo AltoSeed–Late Stage$5M – $40M
17 people
Shield Capital
San FranciscoSeed–Series A
32 people
Sterling Road
San FranciscoPre-Seed–Seed$25K – $150K
11 people
Crit Ventures
SeoulSeed–Series A
13 people
LifeX Ventures
San FranciscoPre-Seed–Series A
22 people
Wesley Clover International Corporation
OttawaSeed–Growth
36 people
SE Ventures
Menlo ParkPre-Seed–Series B
24 people
Ventech China
ShanghaiPre-Seed–Series B
21 people
Leo Capital Ventures
SingaporePre-Seed–Seed
20 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
BMW i Ventures
Mountain ViewSeed–Series B$10M
17 people
Morgan Creek Capital
Chapel HillSeed–Late Stage$1M – $5M
29 people
Toronto Business Development Centre (TBDC)
TorontoSeed
49 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
36 people
IGNIA
Mexico CitySeed–Series A$100K – $5M
20 people
Day One Ventures
San FranciscoPre-Seed–Series C$100K – $5M
7 people
RedBird Capital Partners
New YorkSeed–Late Stage
25 people
ACME Capital
San FranciscoPre-Seed–Growth
13 people
SaaS Capital
SeattleGrowth
15 people
Nimble Partners
San FranciscoSeed–Late Stage
11 people
NIV
New YorkPre-Seed–Series A$500K – $5M
11 people
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)AI & Machine Learning Seed Investors & VC Firms (4380)
Data sourced from public filings and firms' own websites — see our methodology.













































































































